跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Avaxim 80 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Avaxim 80
Approved
STANDARD
Avaxim 80
Sanofi Pasteur
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
aa80caa915e289b2
Company
Sanofi Pasteur
Type
Standard
Approval Details
Approval Id
aa80caa915e289b2
Drug Approval Philippines Name
Avaxim 80
Product Name
Avaxim 80
Registration Number
BR-513
Brand Name
Avaxim 80
Generic Name
Hepatitis A Vaccine (Inactivated, Adsorbed)
Dosage Form
Suspension for Injection (IM)
Dosage Strength
Formulation: Each dose (0.5 mL) contains: Hepatitis A virus, GBM Strain* (inactivated)** *Cultured on MRC-5 human diploid cells 80 ELISA units***
Manufacturer
Sanofi Pasteur
Importer
Sanofi Pasteur, Inc.
Distributor
Zuellig Pharma Corporation.
Company Detail Path
/organization/sanofi-pasteur
Issuance Date
28 May 2025
Expiry Date
28 May 2030
Pharmacologic Category
Vaccines
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
aa80caa915e289b2
Type
Standard
Back to Philippines FDA Approvals